News & Articles
Announcements, discoveries, and leadership in the field.
-
Senda Biosciences Appoints Luke O’Neill, Ph.D., as Chief Scientific OfficerSenda Biosciences
-
Senda Biosciences Appoints MIT Institute Professor Paula Hammond, Ph.D., to Its Board of DirectorsSenda Biosciences
-
Senda Biosciences Bolsters Executive Leadership TeamSenda Biosciences
-
Senda Biosciences Announces Close of $123 Million Series C FinancingSenda Biosciences
-
Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform BiologySenda Biosciences
-
Senda Biosciences Strengthens Leadership Team with Key Management HiresSenda Biosciences
-
Senda Biosciences Announces Closing of $98 Million Series B FinancingSenda Biosciences
-
Senda Biosciences to virtually present at the Chardan 3rd Annual Microbiome Medicines SummitSenda Biosciences
-
Senda Biosciences and Nestlé Health Science announce exclusive global development & option agreement for Senda's Programmable Medicines-based metabolic health productsSenda Biosciences
-
Senda Biosciences Announces Formation of World-Class Scientific Advisory BoardSenda Biosciences